Shionogi & Co., Ltd. (FRA:SH0)

Germany · Delayed Price · Currency is EUR

19.00

+0.50 (2.70%)

Last updated: Feb 20, 2026, 8:01 AM CET

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Prescription Drugs	438.27B	435.08B	426.68B	335.14B	297.18B
Prescription Drugs Growth	0.73%	1.97%	27.32%	12.77%	-10.86%
Total	438.27B	435.08B	426.68B	335.14B	297.18B
Total Growth	0.73%	1.97%	27.32%	12.77%	-10.86%

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Japan	130.00B	155.28B	207.78B	113.59B	118.59B
Japan Growth	-16.28%	-25.27%	82.92%	-4.22%	-5.76%
United States of America	23.44B	18.03B	16.25B	14.32B	8.95B
United States of America Growth	29.98%	10.98%	13.44%	60.00%	-21.84%
Others	19.15B	17.77B	17.67B	15.59B	15.11B
Others Growth	7.81%	0.54%	13.36%	3.17%	-21.53%
Europe (Excl. UK)	20.16B	17.70B	10.28B	7.43B	9.06B
Europe (Excl. UK) Growth	13.89%	72.27%	38.36%	-18.02%	-58.60%
United Kingdom	245.51B	201.29B	174.71B	184.20B	145.46B
United Kingdom Growth	21.97%	15.22%	-5.16%	26.64%	-6.12%
North America (Excl. US)	-	5.00M	6.00M	8.00M	12.00M
North America (Excl. US) Growth	-	-16.67%	-25.00%	-33.33%	140.00%
Total	438.27B	410.07B	426.68B	335.14B	297.18B
Total Growth	6.88%	-3.89%	27.32%	12.77%	-10.86%

Source: S&P Global Market Intelligence.